FTC Urges 2nd Circ. To Overturn Tamoxifen Precedent
The Federal Trade Commission has urged a federal appeals court to grant an en banc rehearing in a lawsuit over a "pay-for-delay" deal Bayer AG cut with Barr Laboratories Inc. to...To view the full article, register now.
Already a subscriber? Click here to view full article